US7080621045 - Common Stock

**PNNT** gets a fundamental rating of **4** out of 10. The analysis compared the fundamentals against 220 industry peers in the **Capital Markets** industry. Both the profitability and the financial health of **PNNT** get a neutral evaluation. Nothing too spectacular is happening here. **PNNT** has a valuation in line with the averages, but on the other hand it scores bad on growth.

The reported net income has been mixed in the past 5 years: **PNNT** reported negative net income in multiple years.

The reported operating cash flow has been mixed in the past 5 years: **PNNT** reported negative operating cash flow in multiple years.

The **Return On Assets** of **PNNT** (**3.21%**) is comparable to the rest of the industry.

With a **Return On Invested Capital** value of **3.84%**, **PNNT** perfoms like the industry average, outperforming **48.15%** of the companies in the same industry.

The last **Return On Invested Capital** (**3.84%**) for **PNNT** is above the 3 year average (**3.43%**), which is a sign of increasing profitability.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 3.21% | ||

ROE | 8.7% | ||

ROIC | 3.84% |

ROA(3y)2.69%

ROA(5y)1.57%

ROE(3y)4.76%

ROE(5y)2.8%

ROIC(3y)3.43%

ROIC(5y)3.33%

Looking at the **Profit Margin**, with a value of **30.24%**, **PNNT** is in the better half of the industry, outperforming **70.83%** of the companies in the same industry.

Looking at the **Operating Margin**, with a value of **45.15%**, **PNNT** is in the better half of the industry, outperforming **75.00%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 45.15% | ||

PM (TTM) | 30.24% | ||

GM | 49.69% |

OM growth 3Y4.56%

OM growth 5Y-0.48%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y5.13%

GM growth 5Y-0.09%

With a **Altman-Z score** value of **0.37**, **PNNT** is not doing good in the industry: **72.69%** of the companies in the same industry are doing better.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.67 | ||

Debt/FCF | N/A | ||

Altman-Z | 0.37 |

ROIC/WACCN/A

WACCN/A

A Current Ratio of **3.80** indicates that **PNNT** has no problem at all paying its short term obligations.

A Quick Ratio of **3.80** indicates that **PNNT** has no problem at all paying its short term obligations.

With an excellent **Quick ratio** value of **3.80**, **PNNT** belongs to the best of the industry, outperforming **84.26%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 3.8 | ||

Quick Ratio | 3.8 |

EPS 1Y (TTM)4.4%

EPS 3Y18.96%

EPS 5Y5.85%

EPS Q2Q%-28.57%

Revenue 1Y (TTM)0.79%

Revenue growth 3Y13.2%

Revenue growth 5Y6.06%

Sales Q2Q%-41.86%

The **Revenue** is expected to decrease by **-2.80%** on average over the next years.

EPS Next Y-7.41%

EPS Next 2Y-5.29%

EPS Next 3Y-6.35%

EPS Next 5YN/A

Revenue Next Year-0.64%

Revenue Next 2Y-1.22%

Revenue Next 3Y-2.8%

Revenue Next 5YN/A

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

With a **Price/Earnings** ratio of **7.38**, the valuation of **PNNT** can be described as very cheap.

Compared to the rest of the industry, the **Price/Earnings** ratio of **PNNT** indicates a rather cheap valuation: **PNNT** is cheaper than 82.41% of the companies listed in the same industry.

The average S&P500 **Price/Earnings** ratio is at **30.52**. **PNNT** is valued rather cheaply when compared to this.

The **Price/Forward Earnings** ratio is **7.74**, which indicates a rather cheap valuation of **PNNT**.

Based on the **Price/Forward Earnings** ratio, **PNNT** is valued cheaply inside the industry as 83.80% of the companies are valued more expensively.

The average S&P500 **Price/Forward Earnings** ratio is at **21.99**. **PNNT** is valued rather cheaply when compared to this.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 7.38 | ||

Fwd PE | 7.74 |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | N/A | ||

EV/EBITDA | N/A |

A cheap valuation may be justified as **PNNT**'s earnings are expected to decrease with **-6.35%** in the coming years.

PEG (NY)N/A

PEG (5Y)1.26

EPS Next 2Y-5.29%

EPS Next 3Y-6.35%

Compared to an average industry **Dividend Yield** of **8.87**, **PNNT** pays a better dividend. On top of this **PNNT** pays more dividend than 81.94% of the companies listed in the same industry.

Compared to an average S&P500 **Dividend Yield** of **2.26**, **PNNT** pays a better dividend.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 12.9% |

The dividend of **PNNT** decreases each year by **-0.76%**.

The dividend of **PNNT** decreased in the last 3 years.

Dividend Growth(5Y)-0.76%

Div Incr Years2

Div Non Decr Years2

DP148.03%

EPS Next 2Y-5.29%

EPS Next 3Y-6.35%

**PENNANTPARK INVESTMENT CORP**

NYSE:PNNT (9/13/2024, 8:04:01 PM)

After market: 7.02 +0.01 (+0.14%)**7.01**

**+0.08 (+1.15%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap457.75M

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 12.9% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 7.38 | ||

Fwd PE | 7.74 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)1.26

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 3.21% | ||

ROE | 8.7% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 45.15% | ||

PM (TTM) | 30.24% | ||

GM | 49.69% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.11

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.67 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 3.8 | ||

Quick Ratio | 3.8 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)4.4%

EPS 3Y18.96%

EPS 5Y

EPS Q2Q%

EPS Next Y-7.41%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)0.79%

Revenue growth 3Y13.2%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y